Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
completednot_applicable

Continuous Glucose Monitoring as Adjunct to Lifestyle Modification in Prediabetes

NCT04588896
recruitingnot_applicable

Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter

NCT06203548
recruitingnot_applicable

KeySteps@JC Phase Two Study

NCT06113042

Clinical Trials (3)

Showing 3 of 3 trials
NCT04588896Not Applicable

Continuous Glucose Monitoring as Adjunct to Lifestyle Modification in Prediabetes

Completed
NCT06203548Not Applicable

Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation Parameter

Recruiting
NCT06113042Not Applicable

KeySteps@JC Phase Two Study

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3